TCI Wealth Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

TCI Wealth Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18	Closed	-$715	–	316
2023 Q1	$715	Buy	+18	New	+$759	﹤0.01%	2159
2022 Q4	–	Sell	-113	Closed	-$4K	–	2497
2022 Q3	$4K	Buy	+113	New	+$3.87K	﹤0.01%	1563
2020 Q1	–	Sell	-15	Closed	-$1K	–	1459
2019 Q4	$1K	Hold	15	–	–	﹤0.01%	1277
2019 Q3	$1K	Hold	15	–	–	﹤0.01%	1220
2019 Q2	$1K	Hold	15	–	–	﹤0.01%	1136
2019 Q1	$1K	Hold	15	–	–	﹤0.01%	1143
2018 Q4	$1K	Hold	15	–	–	﹤0.01%	1136
2018 Q3	$1K	Hold	15	–	–	﹤0.01%	1151
2018 Q2	$1K	Hold	15	–	–	﹤0.01%	1234
2018 Q1	$1K	Hold	15	–	–	﹤0.01%	1081
2017 Q4	$1K	Hold	15	–	–	﹤0.01%	1131
2017 Q3	$1K	Hold	15	–	–	﹤0.01%	1058
2017 Q2	$1K	Hold	15	–	–	﹤0.01%	1087
2017 Q1	$1K	Hold	15	–	–	﹤0.01%	1035
2016 Q4	$1K	Hold	15	–	–	﹤0.01%	1116
2016 Q3	$1K	Hold	15	–	–	﹤0.01%	1075
2016 Q2	$1K	Buy	+15	New	+$729	﹤0.01%	1020

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

TCI Wealth Advisors's ANIP Position: Q2 2023 in Review

TCI Wealth Advisors sold out of ANI Pharmaceuticals (ANIP) in Q2 2023, closing a stake of 18 shares — an estimated $715 sold.

TCI Wealth Advisors first reported a position in ANIP in Q2 2016 and held it in 17 quarters. The position peaked at $4K in Q3 2022. 171 funds tracked by Wall St. Rank hold ANIP as of Q2 2023.

TCI Wealth Advisors reported no remaining ANI Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 18 ANI Pharmaceuticals shares in Q2 2023, an estimated $715.
TCI Wealth Advisors first reported a position in ANI Pharmaceuticals in Q2 2016 and held it in 17 quarters.
TCI Wealth Advisors's ANI Pharmaceuticals position peaked at $4K in Q3 2022.
171 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.